Sio Capital Management »

Enanta Pharmaceuticals shares owned by Sio Capital Management

Quarter-by-quarter ownership of Enanta Pharmaceuticals (ENTA) shares owned by Sio Capital Management from 13F filings

Historical chart of Sio Capital Management investment in Enanta Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Enanta Pharmaceuticals held by Sio Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enanta Pharmaceuticals by Sio Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.1M 177k 17.46

More positions owned by Sio Capital Management

Laboratory Corporation Of America Holdings Com New (LH)
Insmed Com Par $.01 Put Option (INSM)
Cigna Corp (CI)
Globus Medical Cl A (GMED)
Madrigal Pharmaceuticals (MDGL)
GSK Sponsored Adr (GSK)
Zimmer Holdings (ZBH)
Ironwood Pharmaceuticals Com Cl A (IRWD)
Medtronic SHS (MDT)
Organon & Co Common Stock (OGN)
Tyra Biosciences (TYRA)
Embecta Corp Common Stock (EMBC)
Teleflex Incorporated (TFX)
Arcutis Biotherapeutics (ARQT)
Bridgebio Pharma (BBIO)

View all positions for Sio Capital Management

Top funds holding Enanta Pharmaceuticals

Farallon Capital Management
Morgan Stanley
Vanguard Group
BlackRock
Armistice Capital
Krensavage Asset Management
Marshall Wace
Northern Trust
Caligan Partners
Acadian Asset Management
Millennium Management
Assenagon Asset Management
Soleus Capital Management
D. E. Shaw & Co
Renaissance Technologies

View all funds holding Enanta Pharmaceuticals